Zhang Lei portfolio
HHLR Advisors (Hillhouse) · Long-term growth, heavy in China
HHLR Advisors (Hillhouse)'s 13F filing for Q2 2026, filed with the SEC on August 14, 2026, reports $832.1M across 35 US-listed positions. The largest holding is LEGN at 20.8% of the portfolio; the ten largest make up 86%. The largest buy last quarter was VIPS ($44.4M).
Key facts
- 13F portfolio value
- $832.1MQ2 2026
- Positions
- 35
- Largest holding
- LEGN 20.8%
- Top 10 share
- 86%
- New positions
- 5since Q1 2026
- Sold out
- 8
- Filed
- Aug 14, 2026
- Next 13F due
- Nov 16, 2026Q3 2026
Holdings as of (Q2 2026), filed with the SEC on . Changes are measured against the filing for Mar 31, 2026. Source: SEC EDGAR, Form 13F-HR of HHLR Advisors (Hillhouse) (CIK 1762304).
Prices as of .
Compared with Q1 2026, Zhang Lei opened 5 new positions (ALMR, ODTX, NTES…), added to 6, trimmed 7, sold out of 8 (ONC, Clearwater Analytics Holdings, B…).
By sector, Health Care is the largest at 21% of the reported portfolio, followed by Financials at 20%; 34% is in securities with no sector on file.
18 of the 35 positions listed have been in every one of the last 9 quarterly filings.
Zhang Lei top holdings: stocks in the Q2 2026 13F
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Price now | Since period end | Held | Last quarter |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Legend Biotech CorpLEGN · SPONSORED ADS | Health Care | 20.8% | $172.8M | 5.98M | $28.88 | $16.29 | 43.6% down | 9+ qtrs | No change |
| 2 | Futu Holdings LtdFUTU · SPON ADS CL A | Financials | 19.9% | $165.8M | 1.77M | $93.74 | $87.27 | 6.9% down | 9+ qtrs | ▲ Added 25% |
| 3 | Arrivent Biopharma IncAVBP | — | 16.4% | $136.5M | 3.93M | $34.74 | $11.14 | 67.9% down | 9+ qtrs | No change |
| 4 | Marvell Technology IncMRVL | Technology | 5.83% | $48.5M | 162.93K | $297.89 | $146.79 | 50.7% down | 2 qtrs | ▼ Reduced 4.7% |
| 5 | Vipshop Holdings LtdVIPS · SPONSORED ADS A | Consumer Discretionary | 5.53% | $46M | 3.47M | $13.26 | $12.95 | 2.3% down | 2 qtrs | ▲ Added more than 10× |
| 6 | PDD Holdings IncPDD · SPONSORED ADS | Consumer Discretionary | 4.58% | $38.1M | 500K | $76.28 | $77.86 | 2.1% up | 9+ qtrs | ▼ Reduced 88% |
| 7 | KE Holdings IncBEKE · SPONSORED ADS | Real Estate | 3.87% | $32.2M | 2.22M | $14.53 | $18.60 | 28.0% up | 9+ qtrs | ▼ Reduced 48% |
| 8 | Cytek Biosciences IncCTKB | — | 3.54% | $29.5M | 6.66M | $4.43 | $5.68 | 28.1% up | 9+ qtrs | No change |
| 9 | Alamar Biosciences IncALMR | — | 3.11% | $25.9M | 956.46K | $27.09 | $30.58 | 12.9% up | 1 qtr | New |
| 10 | Alibaba Group Holding LtdBABA · SPONSORED ADS | Consumer Discretionary | 2.12% | $17.7M | 183.93K | $95.98 | $87.11 | 9.2% down | 9+ qtrs | ▼ Reduced 93% |
| 11 | Odyssey Therapeutics IncODTX | — | 1.87% | $15.6M | 831.66K | $18.71 | $19.54 | 4.4% up | 1 qtr | New |
| 12 | Yatsen Holding LtdYSG · SPONSORED ADS | — | 1.86% | $15.5M | 4.89M | $3.17 | $2.12 | 33.0% down | 9+ qtrs | No change |
| 13 | Novabridge BiosciencesNBP · SPONSORED ADS | — | 1.40% | $11.7M | 5.98M | $1.95 | $0.7701 | 60.5% down | 9+ qtrs | No change |
| 14 | Contineum Therapeutics IncCTNM · CL A | — | 1.32% | $11M | 669.34K | $16.39 | $9.54 | 41.8% down | 9+ qtrs | No change |
| 15 | Maze Therapeutics IncMAZE | — | 1.31% | $10.9M | 366.03K | $29.84 | $33.28 | 11.5% up | 6 qtrs | No change |
| 16 | Agora IncAPI · ADS | — | 1.01% | $8.4M | 2.1M | $3.99 | $3.73 | 6.6% down | 7 qtrs | No change |
| 17 | Taiwan Semiconductor Manufacturing Company LtdTSM · SPONSORED ADS | Technology | 0.89% | $7.4M | 15.51K | $477.57 | $361.50 | 24.3% down | 3 qtrs | ▼ Reduced 0.06% |
| 18 | Sagimet Biosciences IncSGMT | — | 0.67% | $5.6M | 724.8K | $7.73 | $9.98 | 29.1% up | 9+ qtrs | No change |
| 19 | NetEase IncNTES · SPONSORED ADS | Technology | 0.54% | $4.5M | 35K | $128.14 | $119.87 | 6.5% down | 1 qtr | New |
| 20 | GE AerospaceGE | Industrials | 0.45% | $3.8M | 10.04K | $373.73 | $327.12 | 12.5% down | 9+ qtrs | No change |
| 21 | Lumentum Hldgs IncLITE | Technology | 0.34% | $2.8M | 3.3K | $858.06 | $554.56 | 35.4% down | 2 qtrs | ▲ Added 120% |
| 22 | NVIDIA CorpNVDA | Technology | 0.34% | $2.8M | 14.05K | $200.09 | $154.76 | 22.7% down | 2 qtrs | ▲ Added 113% |
| 23 | Tuya IncTUYA · SPONSERED ADS | — | 0.33% | $2.8M | 1.56M | $1.76 | $1.58 | 10.2% down | 9+ qtrs | No change |
| 24 | Corning IncGLW | Technology | 0.32% | $2.6M | 10.27K | $255.43 | $107.34 | 58.0% down | 2 qtrs | ▲ Added 33% |
| 25 | Coherent CorpCOHR | Technology | 0.30% | $2.5M | 6.42K | $394.47 | $209.02 | 47.0% down | 2 qtrs | ▲ Added 50% |
| 26 | Webull CorpBULL · ORD SHS | — | 0.24% | $2M | 309.86K | $6.52 | $4.83 | 26.0% down | 5 qtrs | ▼ Reduced 79% |
| 27 | Intel CorpINTC | Technology | 0.24% | $2M | 14.3K | $139.63 | $54.25 | 61.1% down | 2 qtrs | ▼ Reduced 51% |
| 28 | Pacific Biosciences of California IncPACB | — | 0.19% | $1.5M | 918.89K | $1.68 | $1.83 | 8.6% up | 9+ qtrs | No change |
| 29 | Texas Instruments IncTXN | Technology | 0.17% | $1.4M | 4.8K | $298.07 | $296.11 | 0.7% down | 1 qtr | New |
| 30 | Mogu IncMOGU · SPON ADS | — | 0.17% | $1.4M | 847.51K | $1.67 | $1.88 | 12.6% up | 9+ qtrs | No change |
| 31 | Gossamer Bio IncGOSS | — | 0.10% | $818.7K | 4.97M | $0.1646 | $10.55 | — | 9+ qtrs | No change |
| 32 | Equinox Gold CorpEQX | Materials | 0.09% | $782.5K | 80.5K | $9.72 | $9.99 | 2.7% up | 4 qtrs | No change |
| 33 | Zoom Communications IncZM · CL A | Technology | 0.09% | $777.7K | 9.01K | $86.31 | $92.33 | 7.0% up | 1 qtr | New |
| 34 | Aligos Therapeutics IncALGS | — | 0.05% | $439.9K | 76.25K | $5.77 | $1.44 | 75.0% down | 9+ qtrs | No change |
| 35 | Ridgetech IncRDGT · SHS NEW | — | 0.00% | $204 | 136 | $1.50 | $0.9610 | 35.9% down | 9+ qtrs | — |
Zhang Lei latest buys (Q2 2026)
Zhang Lei latest sells (Q2 2026)
Every buy and sell in Zhang Lei's Q2 2026 13F →
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Health Care | 20.8% | $172.8M | 1 |
| Financials | 19.9% | $165.8M | 1 |
| Consumer Discretionary | 12.2% | $101.8M | 3 |
| Technology | 9.07% | $75.4M | 10 |
| Real Estate | 3.87% | $32.2M | 1 |
| Industrials | 0.45% | $3.8M | 1 |
| Materials | 0.09% | $782.5K | 1 |
| No sector on file | 33.6% | $279.5M | 17 |
8 quarterly filings on file for HHLR Advisors, back to Q3 2024: reported value, position counts, and every buy and sell quarter by quarter.
Filing history →All Q2 2026 13F filings →Questions about Zhang Lei's portfolio
What stocks does Zhang Lei own?
According to HHLR Advisors' 13F filing for Q2 2026, the largest of its 35 US-listed positions are LEGN (20.8%), FUTU (19.9%), AVBP (16.4%), MRVL (5.8%) and VIPS (5.5%). A 13F shows long positions only, as of the quarter's end.
What is Zhang Lei's largest holding?
LEGN (Legend Biotech Corp), worth $172.8M at the end of Q2 2026, or 20.8% of the $832.1M HHLR Advisors reported.
What did Zhang Lei buy last quarter?
In Q2 2026, compared with the filing for Q1 2026, the largest purchases were VIPS (added, $44.4M), FUTU (added, $32.7M), ALMR (new position, $25.9M), ODTX (new position, $15.6M) and NTES (new position, $4.5M).
What did Zhang Lei sell last quarter?
In Q2 2026 the largest sales were ONC (sold out, $307.2M), PDD (reduced, $279.7M), BABA (reduced, $217.7M), Clearwater Analytics Holdings (sold out, $32.3M) and BEKE (reduced, $29.3M), against the filing for Q1 2026.
How much is Zhang Lei's portfolio worth?
HHLR Advisors reported $832.1M in 35 US-listed positions for Q2 2026, valued at the quarter's end and filed on August 14, 2026. That is the 13F portfolio only: no cash, short positions or most shares listed outside the US.
When does Zhang Lei file the next 13F?
The 13F for Q3 2026, the quarter ending September 30, 2026, was due by November 16, 2026: 45 days after the quarter ends, or the next business day. The latest filing on file here is for Q2 2026, filed on August 14, 2026.
Which sectors does Zhang Lei own?
Health Care 20.8%, Financials 19.9%, Consumer Discretionary 12.2%, Technology 9.1%, Real Estate 3.9% of the reported portfolio, with 33.6% in securities that have no sector on file here (funds, smaller companies, positions without a ticker).
How long has Zhang Lei held these stocks?
Counting consecutive quarterly filings up to Q2 2026: LEGN 9+, FUTU 9+, AVBP 9+, MRVL 2, VIPS 2, PDD 9+. “9+” means the position is in every filing looked at, so it may go back further.
Learn
Cite this page
Funkfolio, “Zhang Lei portfolio: HHLR Advisors (Hillhouse) 13F holdings (Q2 2026)”, data as of 14 August 2026. https://funkfolio.com/gurus/hillhouse
Underlying data: SEC EDGAR, Form 13F-HR of HHLR Advisors (Hillhouse) (CIK 1762304) for the period ending June 30, 2026.
Source: SEC EDGAR, Form 13F-HR for HHLR Advisors (Hillhouse) (CIK 1762304), period ending Jun 30, 2026, filed Aug 14, 2026. “Last quarter” compares share counts with the filing for Mar 31, 2026. “Reported price” is the position's reported value divided by its shares — the price the filing implies for the period end. “Price now” is from Yahoo Finance and can be delayed 15 minutes or more; “since period end” sets the two side by side and is left blank where they cannot be (1 of the 35 priced positions here: the reported price falls outside the stock's 52-week range, which points to a share split since, or the range is not known). A split small enough to stay inside that range is not caught, and dividends are not counted. Sectors are those of the ranked companies on this site; funds, smaller companies and positions without a ticker have none. “Held” counts consecutive quarterly filings the position appears in, out of the 9 looked at. A buy or sell is sized as the shares moved at the price the filing implies; a position sold out at its value in the previous filing. Filings can be 45 days old when published; this is not a live portfolio and not advice.